JESSIE CREAKBAUM: Open Payments
NPI 1295107597 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$458 in 22 payments from 10 companies in 2025. Trend: 2023 $734 · 2024 $667 · 2025 $458
Food & beverage: $458
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $120 |
| Novo Nordisk Inc | 4 | $91 |
| Lilly USA, LLC | 2 | $44 |
| PFIZER INC. | 2 | $39 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $32 |
| Corcept Therapeutics | 1 | $28 |
| Janssen Pharmaceuticals, Inc | 1 | $24 |
| Abbott Laboratories | 1 | $24 |
| Stryker Corporation | 1 | $22 |
Products named: QULIPTA, Wegovy, XIFAXAN, JARDIANCE, Ozempic, MOUNJARO, Korlym, SPRAVATO.
Industry payments across VA — which companies pay providers there.
